AppliedVR raises $36M, pursues FDA clearance of first digital therapeutic
The company is developing a digital therapeutic using VR to manage chronic lower back pain. It recently submitted an application for de novo clearance to the FDA.
The company is developing a digital therapeutic using VR to manage chronic lower back pain. It recently submitted an application for de novo clearance to the FDA.
The company, which offers an AI platform that provides personalized health coaching for chronic disease patients, will use the new funds to invest in research and development and to expand its virtual integrations with health plans and employers.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Though the Medicare Advantage-focused insurance technology startup is smaller than rivals like Clover Health in terms of membership and revenues, this latest financing round places it ahead of, or at least on par with, several larger competitors with regard to total funds raised.
Brave Care leverages its technology and data platform to provide primary and urgent care for children. It provides care remotely and through its five brick-and-mortar clinics, which it plans to expand to 100 in the next few years.
Elligo Health Research uses EHR data, technology and services to expand patient access to clinical trials. It will use the new funds to further invest in its technology platform and purchase research practice management company ClinEdge.
The company, which helps health systems operate virtual care programs through its platform, will use the new funds to scale its go-to-market efforts, invest in the development of new capabilities and hire new employees.
Tia, a concierge clinic combining primary care and OBGYN services, recently raised $100 million in funding. Amid a surge of financing into women’s health startups, CEO Carolyn Witte said investors’ perspectives are changing.
The maternal care startup is backed by major health systems including MemorialCare Health System, whose innovation arm led the most recent funding round. Babyscripts offers a mobile app providing education and resources for the pregnancy and postpartum journey.
The company, which partners with health systems and schools to provide virtual therapy services for kids, will use the Series A funds to expand. The round was led by New Capital Partners, with participation from LRVHealth and OSF Ventures.
The company offers clinical triage via an artificial intelligence-powered chatbot and unlimited virtual visits through a majority of its plans. Inspired by the Israeli healthcare system, patients on Antidote plans pay a monthly membership fee.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
The company, which provides telemedicine and digital programs focused on maternal health, will use the funds raised to expand its services to new populations, including international patients and Medicaid members.
Reify, which makes software for clinical trial recruitment and decentralized clinical trials, raised $220 million in a funding round led by Coatue Management.
The company offers a remote patient monitoring platform that enables clinicians to not only monitor patients at home but also provide personalized feedback via texts and video visits. The platform will be deployed at LifePoint Health facilities and used to deliver remote care to more than 100,000 patients.
In the second quarter of 2021, the top five deals alone were worth $1.6 billion, representing 30% of the total funding raised. In addition, six telehealth companies joined the unicorn club, including LetsGetChecked and Thirty Madison.
The Patient-Centered Outcomes Research Institute has awarded the funds to studies that span a range of healthcare issues, including maternal care, suicide prevention and clinical effectiveness research in arenas like telemedicine and diabetes.